<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10060000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P35408</UniProt_ID>
  <Seq_Length>488</Seq_Length>
  <Molecule_Weight>53119</Molecule_Weight>
  <KEGG_ID>hsa:5734</KEGG_ID>
  <Orthology_ID>K04261</Orthology_ID>
  <Function_Summary>Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>2</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>PGE receptor EP4 subtype</Alias>
      <Alias>PGE2 receptor EP4 subtype</Alias>
      <Alias>Prostanoid EP4 receptor</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with prostaglandin E (PGE(2)) to initiate a change in cell activity.</Detail>
      <Keyword>Prostaglandin E receptor activity</Keyword>
      <Ontology_ID>GO:0004957</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil extravasation.</Detail>
      <Keyword>Negative regulation of eosinophil extravasation</Keyword>
      <Ontology_ID>GO:2000420</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a relatively unspecialized thymocyte acquires specialized features of a T-helper cell.</Detail>
      <Keyword>T-helper cell differentiation</Keyword>
      <Ontology_ID>GO:0042093</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.</Detail>
      <Keyword>Response to lipopolysaccharide</Keyword>
      <Ontology_ID>GO:0032496</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Negative regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050728</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of integrin activation.</Detail>
      <Keyword>Negative regulation of integrin activation</Keyword>
      <Ontology_ID>GO:0033624</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of bone formation.</Detail>
      <Keyword>Regulation of ossification</Keyword>
      <Ontology_ID>GO:0030278</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of protein kinase activities, culminating in the phosphorylation and activation of either the ERK1 or ERK2 kinases, which in turn are a subfamily of mitogen-activated protein (MAP) kinases.</Detail>
      <Keyword>ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070371</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cytokines from a cell or group of cells.</Detail>
      <Keyword>Negative regulation of cytokine secretion</Keyword>
      <Ontology_ID>GO:0050710</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.</Detail>
      <Keyword>Regulation of stress fiber assembly</Keyword>
      <Ontology_ID>GO:0051492</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell or group of cells.</Detail>
      <Keyword>Positive regulation of cytokine secretion</Keyword>
      <Ontology_ID>GO:0050715</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.</Detail>
      <Keyword>Bone development</Keyword>
      <Ontology_ID>GO:0060348</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by modulation of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP.</Detail>
      <Keyword>G-protein signaling, coupled to cAMP nucleotide second messenger</Keyword>
      <Ontology_ID>GO:0007188</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Positive regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.</Detail>
      <Keyword>Cellular response to mechanical stimulus</Keyword>
      <Ontology_ID>GO:0071260</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of protein kinase activities, culminating in the phosphorylation and activation of a member of the JUN kinase subfamily of stress-activated protein kinases, which in turn are a subfamily of mitogen-activated protein (MAP) kinases that is activated primarily by cytokines and exposure to environmental stress.</Detail>
      <Keyword>JNK cascade</Keyword>
      <Ontology_ID>GO:0007254</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>382</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>374</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>377</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>379</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI</Protein_Seq>
    <DNA_Seq>GCGAGAGCGGAGCTCCAAGCCCGGCAGCCCGAGAGGAAGATGAACAGCCCCAGGCCAGAGCCTCTGGCAGAGTGGACCCCGAGCCGCCCCCAGGTAGCCAGGAGCGGCCTCAGCGGCAGCCGCAAACTCCAGTAGCCGCCCGTGCTGCCCGTGGCTGGGGCGGAGGGCAGCCAGAGCTGGGGACCAAGGCTCCGCGCCACCTGCGCGCACAGCCTCACACCTGAACGCTGTCCTCCCGCAGACGAGACCGGCGGGCACTGCAAAGCTGGGACTCGTCTTTGAAGGAAAAAAAATAGCGAGTAAGAAATCCAGCACCATTCTTCACTGACCCATCCCGCTGCACCTCTTGTTTCCCAAGTTTTTGAAAGCTGGCAACTCTGACCTCGGTGTCCAAAAATCGACAGCCACTGAGACCGGCTTTGAGAAGCCGAAGATTTGGCAGTTTCCAGACTGAGCAGGACAAGGTGAAAGCAGGTTGGAGGCGGGTCCAGGACATCTGAGGGCTGACCCTGGGGGCTCGTGAGGCTGCCACCGCTGCTGCCGCTACAGACCCAGCCTTGCACTCCAAGGCTGCGCACCGCCAGCCACTATCATGTCCACTCCCGGGGTCAATTCGTCCGCCTCCTTGAGCCCCGACCGGCTGAACAGCCCAGTGACCATCCCGGCGGTGATGTTCATCTTCGGGGTGGTGGGCAACCTGGTGGCCATCGTGGTGCTGTGCAAGTCGCGCAAGGAGCAGAAGGAGACGACCTTCTACACGCTGGTATGTGGGCTGGCTGTCACCGACCTGTTGGGCACTTTGTTGGTGAGCCCGGTGACCATCGCCACGTACATGAAGGGCCAATGGCCCGGGGGCCAGCCGCTGTGCGAGTACAGCACCTTCATTCTGCTCTTCTTCAGCCTGTCCGGCCTCAGCATCATCTGCGCCATGAGTGTCGAGCGCTACCTGGCCATCAACCATGCCTATTTCTACAGCCACTACGTGGACAAGCGATTGGCGGGCCTCACGCTCTTTGCAGTCTATGCGTCCAACGTGCTCTTTTGCGCGCTGCCCAACATGGGTCTCGGTAGCTCGCGGCTGCAGTACCCAGACACCTGGTGCTTCATCGACTGGACCACCAACGTGACGGCGCACGCCGCCTACTCCTACATGTACGCGGGCTTCAGCTCCTTCCTCATTCTCGCCACCGTCCTCTGCAACGTGCTTGTGTGCGGCGCGCTGCTCCGCATGCACCGCCAGTTCATGCGCCGCACCTCGCTGGGCACCGAGCAGCACCACGCGGCCGCGGCCGCCTCGGTTGCCTCCCGGGGCCACCCCGCTGCCTCCCCAGCCTTGCCGCGCCTCAGCGACTTTCGGCGCCGCCGGAGCTTCCGCCGCATCGCGGGCGCCGAGATCCAGATGGTCATCTTACTCATTGCCACCTCCCTGGTGGTGCTCATCTGCTCCATCCCGCTCGTGGTGCGAGTATTCGTCAACCAGTTATATCAGCCAAGTTTGGAGCGAGAAGTCAGTAAAAATCCAGATTTGCAGGCCATCCGAATTGCTTCTGTGAACCCCATCCTAGACCCCTGGATATATATCCTCCTGAGAAAGACAGTGCTCAGTAAAGCAATAGAGAAGATCAAATGCCTCTTCTGCCGCATTGGCGGGTCCCGCAGGGAGCGCTCCGGACAGCACTGCTCAGACAGTCAAAGGACATCTTCTGCCATGTCAGGCCACTCTCGCTCCTTCATCTCCCGGGAGCTGAAGGAGATCAGCAGTACATCTCAGACCCTCCTGCCAGACCTCTCACTGCCAGACCTCAGTGAAAATGGCCTTGGAGGCAGGAATTTGCTTCCAGGTGTGCCTGGCATGGGCCTGGCCCAGGAAGACACCACCTCACTGAGGACTTTGCGAATATCAGAGACCTCAGACTCTTCACAGGGTCAGGACTCAGAGAGTGTCTTACTGGTGGATGAGGCTGGTGGGAGCGGCAGGGCTGGGCCTGCCCCTAAGGGGAGCTCCCTGCAAGTCACATTTCCCAGTGAAACACTGAACTTATCAGAAAAATGTATATAATAGGCAAGGAAAGAAATACAGTACTGTTTCTGGACCCTTATAAAATCCTGTGCAATAGACACATACATGTCACATTTAGCTGTGCTCAGAAGGGCTATCATCATCCTACAACTCACATTAGAGAACATCCTGGCTTTTGAGCACTTTTCAAACAATCAAGTTGACTCACGTGGGTCCTGAGGCCTGCAGCACGTCGGATGCTACCCCACTATGACAGAGGATTGTGGTCACAACTTGATGGCTGCGAAGACCTACCCTCCGTTTTTCTACTAGATAGGAGGATGGTAGAAGTTTGGCTGCTGTCATAACATCCAGAGCTTTGTCGTATTTGGCACACAGCAGAGGCCCAGATATTAGAAAGGCTCTATTCCAATAAACTATGAGGACTGCCTTATGGATGATTTAAGTGTCTCACTAAAGCATGAAATGTGAATTTTTATTGTTGTACATACGATTTAAGGTATTTAAAGTATTTTCTTCTCTGTGAGAAGGTTTATTGTTAATACAAGGTATAATAAAATTATCGCAACCCCTCTCCTTCCAGTATAACCAGCTGAAGTTGCAGATGTTAGATATTTTTCATAAACAAGTTCGAGTCAAAGTTGAAAATTCATAGTAAGATTGATATCTATAAAATAGATATAAATTTTTAAGAGAAAGAATTTAGTATTATCAAAGGGATAAAGAAAAAAATACTATTTAAGATGTGAAAATTACAGTCCAAAATACTGTTCTTTCCAGGCTATGTATAAAATACATAGTGAAAATTGTTTAGTGATATTACATTTATTTATCCAGAAAACTGTGATTTCAGGAGAACCTAACATGCTGGTGAATATTTTCAACTTTTTCCCTCACTAATTGGTACTTTTAAAAACATAACATAAATTTTTTGAAGTCTTTAATAAATAACCCATAATTGAAGTGTATAATATAAAAAATTTTAAAAATCTAAGCAGCTTATTGTTTCTCTGAAAGTGTGTGTAGTTTTACTTTCCTAAGGAATTACCAAGAATATCCTTTAAAATTTAAAAGGATGGCAAGTTGCATCAGAAAGCTTTATTTTGAGATGTAAAAAGATTCCCAAACGTGGTTACATTAGCCATTCATGTATGTCAGAAGTGCAGAATTGGGGCACTTAATGGTCACCTTGTAACAGTTTTGTGTAACTCCCAGTGATGCTGTACACATATTTGAAGGGTCTTTCTCAAAGAAATATTAAGCATGTTTTGTTGCTCAGTGTTTTTGTGAATTGCTTGGTTGTAATTAAATTCTGAGCCTGATATTGATATGGTTTTAAGAAGCAGTTGTACCAAGTGAAATTATTTTGGAGATTATAATAAATATATACATTCAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Intestine</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Peripheral blood mononuclear cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PTGER4</Gene_Name>
    <Gene_Alias>PTGER2</Gene_Alias>
    <Gene_ID>5734</Gene_ID>
    <Genbank_ACCN>NM_000958</Genbank_ACCN>
    <Protein_ACCN>NP_000949</Protein_ACCN>
    <HGNC_ID>9596</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5734</Gene_URL>
    <UCSC_ID>uc003jlz.3</UCSC_ID>
    <EMBL_ID>ENSG00000171522</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Benign Mesothelioma</Disease_Name>
      <Disease_Detail>Benign Mesothelioma</Disease_Detail>
      <Disease_DB>BNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benign_mesothelioma?search=PTGER4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteoporosis</Disease_Name>
      <Disease_Detail>Osteoporosis</Disease_Detail>
      <Disease_DB>OST002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteoporosis?search=PTGER4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphocytic Colitis</Disease_Name>
      <Disease_Detail>Lymphocytic Colitis</Disease_Detail>
      <Disease_DB>LYM042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphocytic_colitis?search=PTGER4#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of Prostaglandin E2 receptor EP4 subtype</PDB_Title>
      <PDB_ID>ASD10060000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04080</Pathway_ID>
      <Pathway_Title>Neuroactive ligand-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04750</Pathway_ID>
      <Pathway_Title>Inflammatory mediator regulation of TRP channels</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Leduc M, et al. Am J Physiol Regul Integr Comp Physiol. 2012 Nov 14. [Epub ahead of print]</Site_Reference>
      <PubMed_ID>23152113</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD10060001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10060002</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>